| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Weibing Shen, Yaner Zhang, Chenguang Zhou, Yaoyao She. Bilateral symmetrical deep gray matter involvement and leptomeningeal enhancement in a child with MOG-IgG-associated encephalomyelitis. BMC neurology. vol 21. issue 1. 2021-03-16. PMID:33419414. |
currently, myelin oligodendrocyte glycoprotein (mog)-igg-associated encephalomyelitis (mog-em) is regarded as an independent inflammatory demyelinating disease. |
2021-03-16 |
2023-08-13 |
Not clear |
| Kyungsook Jung, Jeongtae Kim, Ginnae Ahn, Hiroshi Matsuda, Tanaka Akane, Meejung Ahn, Taekyun Shi. Alendronate alleviates the symptoms of experimental autoimmune encephalomyelitis. International immunopharmacology. vol 84. 2021-03-15. PMID:32361191. |
eae was induced in c57bl/6 mice by immunization with myelin oligodendrocyte glycoprotein (mog) |
2021-03-15 |
2023-08-13 |
mouse |
| Matthias Baumann, Frederik Bartels, Carsten Finke, Catherine Adamsbaum, Yael Hacohen, Kevin Rostás. E.U. paediatric MOG consortium consensus: Part 2 - Neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33158737. |
paediatric mog consortium consensus: part 2 - neuroimaging features of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. |
2021-03-15 |
2023-08-13 |
Not clear |
| Arlette L Bruijstens, Christian Lechner, Lorraine Flet-Berliac, Kumaran Deiva, Rinze F Neuteboom, Cheryl Hemingway, Evangeline Wassmer, M Baumann, F Bartels, C Finke, C Adamsbaum, Y Hacohen, K Rostas. E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33162302. |
paediatric mog consortium consensus: part 1 - classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. |
2021-03-15 |
2023-08-13 |
Not clear |
| Arlette L Bruijstens, Eva-Maria Wendel, Christian Lechner, Frederik Bartels, Carsten Finke, Markus Breu, Lorraine Flet-Berliac, Aliénor de Chalus, Catherine Adamsbaum, Marco Capobianco, Giorgi Laetitia, Yael Hacohen, Cheryl Hemingway, Evangeline Wassmer, Ming Lim, Matthias Baumann, Ronny Wickström, Thaís Armangue, Kevin Rostasy, Kumaran Deiva, Rinze F Neuteboo. E.U. paediatric MOG consortium consensus: Part 5 - Treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33176999. |
paediatric mog consortium consensus: part 5 - treatment of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. |
2021-03-15 |
2023-08-13 |
Not clear |
| Arlette L Bruijstens, Markus Breu, Eva-Maria Wendel, Evangeline Wassmer, Ming Lim, Rinze F Neuteboom, Ronny Wickström, M Baumann, F Bartels, C Finke, C Adamsbaum, Y Hacohen, K Rostas. E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33183945. |
paediatric mog consortium consensus: part 4 - outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. |
2021-03-15 |
2023-08-13 |
Not clear |
| Thaís Armangue, Marco Capobianco, Aliénor de Chalus, Giorgi Laetitia, Kumaran Deiv. E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33191096. |
paediatric mog consortium consensus: part 3 - biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. |
2021-03-15 |
2023-08-13 |
Not clear |
| Thaís Armangue, Marco Capobianco, Aliénor de Chalus, Giorgi Laetitia, Kumaran Deiv. E.U. paediatric MOG consortium consensus: Part 3 - Biomarkers of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders. European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society. vol 29. 2021-03-15. PMID:33191096. |
recently, antibodies against myelin oligodendrocyte glycoprotein (mog) have emerged as a new ads biomarker, which clearly allow the identification of monophasic and relapsing ads forms different from ms predominantly in children. |
2021-03-15 |
2023-08-13 |
Not clear |
| Alessandra De Paula Pohl, Anja Schmidt, Ai-Hong Zhang, Tania Maldonado, Christoph Königs, David W Scot. Engineered regulatory T cells expressing myelin-specific chimeric antigen receptors suppress EAE progression. Cellular immunology. vol 358. 2021-03-09. PMID:33053469. |
these tcr-engineered specific tregs suppressed the proliferation of mbp-reactive t effector cells and ameliorated myelin oligodendrocyte glycoprotein (mog)-induced experimental autoimmune encephalomyelitis (eae). |
2021-03-09 |
2023-08-13 |
human |
| Fiona Tea, Deepti Pilli, Sudarshini Ramanathan, Joseph A Lopez, Vera Merheb, Fiona X Z Lee, Alicia Zou, Ganesha Liyanage, Chelsea B Bassett, Selina Thomsen, Stephen W Reddel, Michael H Barnett, David A Brown, Russell C Dale, Fabienne Brilo. Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry. Frontiers in immunology. vol 11. 2021-03-08. PMID:32117270. |
human autoantibodies targeting myelin oligodendrocyte glycoprotein (mog ab) have become a useful clinical biomarker for the diagnosis of a spectrum of inflammatory demyelinating disorders. |
2021-03-08 |
2023-08-13 |
human |
| Sakie Miyamura, Nagisa Matsuo, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kanek. Myelin Oligodendrocyte Glycoprotein 35-55 (MOG 35-55)-induced Experimental Autoimmune Encephalomyelitis: A Model of Chronic Multiple Sclerosis. Bio-protocol. vol 9. issue 24. 2021-03-05. PMID:33654948. |
myelin oligodendrocyte glycoprotein 35-55 (mog 35-55)-induced experimental autoimmune encephalomyelitis: a model of chronic multiple sclerosis. |
2021-03-05 |
2023-08-13 |
mouse |
| Sakie Miyamura, Nagisa Matsuo, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kanek. Myelin Oligodendrocyte Glycoprotein 35-55 (MOG 35-55)-induced Experimental Autoimmune Encephalomyelitis: A Model of Chronic Multiple Sclerosis. Bio-protocol. vol 9. issue 24. 2021-03-05. PMID:33654948. |
here we introduce the eae model based on c57bl/6j mice, which is generated by injection of myelin oligodendrocyte glycoprotein 35-55 (mog 35-55) as an antigen. |
2021-03-05 |
2023-08-13 |
mouse |
| John J Chen, Sean J Pittock, Eoin P Flanagan, Vanda A Lennon, M Tariq Bhatt. Optic neuritis in the era of biomarkers. Survey of ophthalmology. vol 65. issue 1. 2021-03-03. PMID:31425702. |
subsequently, myelin oligodendrocyte glycoprotein (mog) igg was recognized to be a marker for mog-igg-associated disorder, a central demyelinating disease characterized by recurrent optic neuritis, prominent disk edema, and perineural optic nerve enhancement on magnetic resonance imaging. |
2021-03-03 |
2023-08-13 |
Not clear |
| Marina Boziki, Styliani-Aggeliki Sintila, Panagiotis Ioannidis, Nikolaos Grigoriadi. Biomarkers in Rare Demyelinating Disease of the Central Nervous System. International journal of molecular sciences. vol 21. issue 21. 2021-03-02. PMID:33182495. |
multiple sclerosis (ms) needs to be differentially diagnosed from rare ms variants, acute disseminated encephalomyelitis (adem), the range of neuromyelitis optica spectrum disorders (nmosds), myelin oligodendrocyte glycoprotein (mog) antibody disease and other systemic inflammatory diseases. |
2021-03-02 |
2023-08-13 |
Not clear |
| Ward Doelman, Mikkel H S Marqvorsen, Fabrizio Chiodo, Sven C M Bruijns, Gijsbert A van der Marel, Yvette van Kooyk, Sander I van Kasteren, Can Arama. Synthesis of Asparagine Derivatives Harboring a Lewis X Type DC-SIGN Ligand and Evaluation of their Impact on Immunomodulation in Multiple Sclerosis. Chemistry (Weinheim an der Bergstrasse, Germany). vol 27. issue 8. 2021-03-01. PMID:33090600. |
the protein myelin oligodendrocyte glycoprotein (mog) is a key component of myelin and an autoantigen in the disease multiple sclerosis (ms). |
2021-03-01 |
2023-08-13 |
Not clear |
| Sotaro Mori, Takuji Kurimoto, Yusuke Murai, Kaori Ueda, Mari Sakamoto, Norio Chihara, Yuko Yamada-Nakanishi, Makoto Nakamur. Efficacy for the Annual Relapse Rate after the Immunosuppressive Therapy in Patients Associated with Anti-AQP4 or Anti-MOG Antibody-Positive Optic Neuritis. Journal of ophthalmology. vol 2020. 2021-02-26. PMID:33628473. |
although oral prednisolone is the first-line treatment for preventing recurrent optic neuritis (on) after the completion of acute-phase treatment, especially anti-aquaporin 4 (aqp4) antibody-positive on, and anti-myelin oligodendrocyte glycoprotein (mog) antibody-positive on, some patients experience relapses. |
2021-02-26 |
2023-08-13 |
Not clear |
| Maria-Eleni Androutsou, Agathi Nteli, Areti Gkika, Maria Avloniti, Anastasia Dagkonaki, Lesley Probert, Theodore Tselios, Simona Golič Grdadolni. Characterization of Asparagine Deamidation in Immunodominant Myelin Oligodendrocyte Glycoprotein Peptide Potential Immunotherapy for the Treatment of Multiple Sclerosis. International journal of molecular sciences. vol 21. issue 20. 2021-02-25. PMID:33066323. |
mannan (polysaccharide) conjugated with a myelin oligodendrocyte glycoprotein (mog) peptide, namely (kg) |
2021-02-25 |
2023-08-13 |
Not clear |
| Soheila Rezapour-Firouzi, Mahshid Mohammadian, Maryam Sadeghzadeh, Sahar Mehranfar, Ebrahim Mazloom. The Effects of Evening Primrose/Hemp Seed Oil Compared to Rapamycin on the Gene Expression of Immunological Parameters in Experimental Autoimmune Encephalomyelitis Splenocytes. Iranian journal of allergy, asthma, and immunology. vol 19. issue 2. 2021-02-09. PMID:32372631. |
we firstly induced eae mice by injection of myelin oligodendrocyte glycoprotein (mog). |
2021-02-09 |
2023-08-13 |
mouse |
| Camila Ritter, Diéssica Padilha Dalenogare, Amanda Spring de Almeida, Vitória Loreto Pereira, Gabriele Cheiran Pereira, Maria Fernanda Pessano Fialho, Débora Denardin Lückemeyer, Caren Tatiane Antoniazzi, Sabrina Qader Kudsi, Juliano Ferreira, Sara Marchesan Oliveira, Gabriela Trevisa. Nociception in a Progressive Multiple Sclerosis Model in Mice Is Dependent on Spinal TRPA1 Channel Activation. Molecular neurobiology. vol 57. issue 5. 2021-02-03. PMID:32095993. |
we used c57bl/6 female mice (20-30 g), and the pms model was induced by the experimental autoimmune encephalomyelitis (eae) using mouse myelin oligodendrocyte glycoprotein (mog |
2021-02-03 |
2023-08-13 |
mouse |
| Alvaro Cobo-Calvo, Anne Ruiz, Fabien Rollot, Georgina Arrambide, Romain Deschamps, Elisabeth Maillart, Caroline Papeix, Bertrand Audoin, Anne Fabienne Lépine, Hélène Maurey, Helene Zephir, Damien Biotti, Jonathan Ciron, Francoise Durand-Dubief, Nicolas Collongues, Xavier Ayrignac, Pierre Labauge, Pierre Meyer, Eric Thouvenot, Bertrand Bourre, Alexis Montcuquet, Mikael Cohen, Philippe Horello, Mar Tintoré, Jerome De Seze, Sandra Vukusic, Kumaran Deiva, Romain Marignie. Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Annals of neurology. vol 89. issue 1. 2021-02-02. PMID:32959427. |
the main objective was to compare clinical features, disease course, and myelin oligodendrocyte glycoprotein (mog) antibody (ab) dynamics between children and adults with mog-ab-associated disease (mogad). |
2021-02-02 |
2023-08-13 |
Not clear |